Versant Venture Capital Vi, L.P. Black Diamond Therapeutics, Inc. (BDTX) insider trading activity

Versant Venture Capital Vi, L.P. is of Black Diamond Therapeutics, Inc.. Currently has a direct ownership of 3.73 Million shares of BDTX, which is worth approximately $14.7 Million. The most recent transaction as insider was on Oct 08, 2020, when has been sold 16,276 shares (Common Stock) at a price of $33.47 per share, resulting in proceeds of $544,758. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 3.73M

5.61% 3M change

5.61% 12M change

Total Value Held $14.7 Million

Versant Venture Capital VI, L.P. Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Oct 08 2020	SELL Open market or private sale	$544,758 $33.47 p/Share	16,276 Reduced 0.28%	5,740,384 Common Stock
Oct 07 2020	SELL Open market or private sale	$825,240 $33.56 p/Share	24,590 Reduced 0.43%	5,756,660 Common Stock
Oct 06 2020	SELL Open market or private sale	$531,495 $33.26 p/Share	15,980 Reduced 0.28%	5,781,250 Common Stock

Also insider at

ALGS

Aligos Therapeutics, Inc. Healthcare

> 10% Shareholder

OYST

Oyster Point Pharma, Inc. Healthcare

> 10% Shareholder

IPSC

Century Therapeutics, Inc. Healthcare

> 10% Shareholder

GLUE

Monte Rosa Therapeutics, Inc. Healthcare

GRPH

Graphite Bio, Inc. Healthcare

CTNM

Contineum Therapeutics, Inc.

> 10% Shareholder

TPST

Tempest Therapeutics, Inc. Healthcare

VVC